Deep Dive: FDA to revoke Red No. 3 authorization
January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.
Cardiomato™ came out on top at this year’s NutraIngredients Awards.
Cardiomato™ came out on top at this year’s NutraIngredients Awards, a global nutraceuticals event produced in association with Vitafoods Europe. Our proprietary blend won a coveted trophy in the Finished Product of the Year – Heart Health category. Our team was proud to accept this honor during the annual awards dinner which was held in Geneva, Switzerland earlier this month. Products were judged based on a diverse range of criteria, including validated research, true innovation, and creative marketing. We are humbled to be placed in the same group as so many other worthy products, and we’re thrilled that our passion and hard work have been recognized. Many thanks to all team members and partners who helped make this happen.
January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.
In our latest webinar, Elizabeth Tarshish, PhD, Head of Scientific Value & Strategy at Lycored discusses Lycomato’s impact on cellular and mitochondrial health and how it promotes longevity through a...
Reflecting on my fourth year at Lycored, I'm filled with gratitude for our incredible journey together in 2024.
Interested in speaking directly with a member of our team?
Click below to get in touch.